There are allegations that China’s practices force foreign companies to part with technology—a backhanded intellectual theft that has been at the heart of the China-US discord. There have been ethical concerns, too (the 2018 gene-editing trials, for example). But China’s strides will, no doubt, be harnessed by the global community, giving billions in the developing world access to quality goods at cheaper prices.